{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:19:37Z","timestamp":1773296377934,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,6,23]],"date-time":"2009-06-23T00:00:00Z","timestamp":1245715200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Myeloperoxidase (MPO) -containing macrophages and neutrophils have been described at sites of plaque rupture. The presence of these cells in precursor lesions to acute rupture (thin cap atheroma, or vulnerable plaque) and within thrombi adjacent to ruptures has not been described, nor an association with iron-containing macrophages within unstable plaques.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We studied 61 acute ruptures, 15 organizing ruptures, 31 thin cap fibroatheromas, and 28 fibroatheromas from 72 sudden coronary death victims by immunohistochemical and histochemical techniques. Inflammatory cells were typed with anti-CD68 (macrophages), anti-BP-30 (neutrophil bactericidal glycoprotein), and anti-MPO. Iron was localized by Mallory's Prussian blue stain. In selected plaques alpha smooth muscle actin (DAKO, Carpinteria, CA, clone M0851) was performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>MPO positive cells were present in 79% of ruptured caps, 28% of thin cap fibroatheroma, and no fibroatheromas; neutrophils were present in 72% of ruptures, 8% of thin cap fibroatheromas, and no fibroatheromas. Iron containing foam cells were present in the caps of 93% of acute ruptures, of 85% of organizing ruptures, 20% of thin cap atheromas, and 10% of fibroatheromas. MPO positive cells were more frequent in occlusive than non-occlusive thrombi adjacent to ruptures (p = .006) and were more numerous in diabetics compared to non-diabetics (p = .002)<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Unstable fibrous caps are more likely to contain MPO-positive cells, neutrophils, and iron-containing macrophages than fibrous caps of stable fibroatheromas. MPO-positive cells in thrombi adjacent to disrupted plaques are associated with occlusive thrombi and are more numerous in diabetic patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2261-9-27","type":"journal-article","created":{"date-parts":[[2009,6,24]],"date-time":"2009-06-24T12:09:04Z","timestamp":1245845344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Monocytes and neutrophils expressing myeloperoxidase occur in fibrous caps and thrombi in unstable coronary plaques"],"prefix":"10.1186","volume":"9","author":[{"given":"Fabio R","family":"Tavora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Ripple","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen P","family":"Burke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,6,23]]},"reference":[{"issue":"10","key":"248_CR1","doi-asserted-by":"publisher","first-page":"114E","DOI":"10.1016\/0002-9149(89)90242-7","volume":"63","author":"E Falk","year":"1989","unstructured":"Falk E: Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes. Am J Cardiol. 1989, 63 (10): 114E-120E. 10.1016\/0002-9149(89)90242-7.","journal-title":"Am J Cardiol"},{"issue":"7","key":"248_CR2","doi-asserted-by":"publisher","first-page":"28B","DOI":"10.1016\/0002-9149(91)90382-U","volume":"68","author":"E Falk","year":"1991","unstructured":"Falk E: Coronary thrombosis: pathogenesis and clinical manifestations. Am J Cardiol. 1991, 68 (7): 28B-35B. 10.1016\/0002-9149(91)90382-U.","journal-title":"Am J Cardiol"},{"issue":"7","key":"248_CR3","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1161\/01.CIR.92.7.1701","volume":"92","author":"A Farb","year":"1995","unstructured":"Farb A, Tang AL, Burke AP, Sessums L, Liang Y, Virmani R: Sudden coronary death. Frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction. Circulation. 1995, 92 (7): 1701-1709.","journal-title":"Circulation"},{"issue":"1","key":"248_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1161\/01.CIR.89.1.36","volume":"89","author":"AC van der Wal","year":"1994","unstructured":"Wal van der AC, Becker AE, Loos van der CM, Das PK: Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994, 89 (1): 36-44.","journal-title":"Circulation"},{"issue":"23","key":"248_CR5","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1161\/01.CIR.0000042674.89762.20","volume":"106","author":"T Naruko","year":"2002","unstructured":"Naruko T, Ueda M, Haze K, Wal van der AC, Loos van der CM, Itoh A, Komatsu R, Ikura Y, Ogami M, Shimada Y, et al: Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation. 2002, 106 (23): 2894-2900. 10.1161\/01.CIR.0000042674.89762.20.","journal-title":"Circulation"},{"issue":"3","key":"248_CR6","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S0002-9440(10)64036-9","volume":"158","author":"S Sugiyama","year":"2001","unstructured":"Sugiyama S, Okada Y, Sukhova GK, Virmani R, Heinecke JW, Libby P: Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol. 2001, 158 (3): 879-891.","journal-title":"Am J Pathol"},{"key":"248_CR7","doi-asserted-by":"publisher","first-page":"135625","DOI":"10.1155\/2008\/135625","volume":"2008","author":"V Loria","year":"2008","unstructured":"Loria V, Dato I, Graziani F, Biasucci LM: Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes. Mediators Inflamm. 2008, 2008: 135625-10.1155\/2008\/135625.","journal-title":"Mediators Inflamm"},{"issue":"2","key":"248_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jacc.2007.03.033","volume":"50","author":"MC Meuwese","year":"2007","unstructured":"Meuwese MC, Stroes ES, Hazen SL, van Miert JN, Kuivenhoven JA, Schaub RG, Wareham NJ, Luben R, Kastelein JJ, Khaw KT, et al: Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol. 2007, 50 (2): 159-165. 10.1016\/j.jacc.2007.03.033.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"248_CR9","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1161\/01.ATV.0000135267.82813.52","volume":"24","author":"SL Hazen","year":"2004","unstructured":"Hazen SL: Myeloperoxidase and plaque vulnerability. Arterioscler Thromb Vasc Biol. 2004, 24 (7): 1143-1146. 10.1161\/01.ATV.0000135267.82813.52.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"248_CR10","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/00041433-200308000-00003","volume":"14","author":"ML Brennan","year":"2003","unstructured":"Brennan ML, Hazen SL: Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment. Curr Opin Lipidol. 2003, 14 (4): 353-359. 10.1097\/00041433-200308000-00003.","journal-title":"Curr Opin Lipidol"},{"issue":"21","key":"248_CR11","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1161\/01.CIR.97.21.2110","volume":"97","author":"AP Burke","year":"1998","unstructured":"Burke AP, Farb A, Malcom GT, Liang Y, Smialek J, Virmani R: Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation. 1998, 97 (21): 2110-2116.","journal-title":"Circulation"},{"issue":"18","key":"248_CR12","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1056\/NEJM199705013361802","volume":"336","author":"AP Burke","year":"1997","unstructured":"Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R: Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med. 1997, 336 (18): 1276-1282. 10.1056\/NEJM199705013361802.","journal-title":"N Engl J Med"},{"issue":"3","key":"248_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1161\/hc0302.102610","volume":"105","author":"AP Burke","year":"2002","unstructured":"Burke AP, Kolodgie FD, Farb A, Weber D, Virmani R: Morphological predictors of arterial remodeling in coronary atherosclerosis. Circulation. 2002, 105 (3): 297-303. 10.1161\/hc0302.102610.","journal-title":"Circulation"},{"issue":"7","key":"248_CR14","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1161\/01.CIR.103.7.934","volume":"103","author":"AP Burke","year":"2001","unstructured":"Burke AP, Kolodgie FD, Farb A, Weber DK, Malcom GT, Smialek J, Virmani R: Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation. 2001, 103 (7): 934-940.","journal-title":"Circulation"},{"issue":"7","key":"248_CR15","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1161\/01.CIR.93.7.1354","volume":"93","author":"A Farb","year":"1996","unstructured":"Farb A, Burke AP, Tang AL, Liang TY, Mannan P, Smialek J, Virmani R: Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation. 1996, 93 (7): 1354-1363.","journal-title":"Circulation"},{"issue":"5","key":"248_CR16","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1161\/01.ATV.20.5.1262","volume":"20","author":"R Virmani","year":"2000","unstructured":"Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM: Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000, 20 (5): 1262-1275.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"248_CR17","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1161\/01.ATV.0000163262.83456.6d","volume":"25","author":"SJ Nicholls","year":"2005","unstructured":"Nicholls SJ, Hazen SL: Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2005, 25 (6): 1102-1111. 10.1161\/01.ATV.0000163262.83456.6d.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"248_CR18","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/S0891-5849(00)00229-X","volume":"28","author":"EA Podrez","year":"2000","unstructured":"Podrez EA, Abu-Soud HM, Hazen SL: Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic Biol Med. 2000, 28 (12): 1717-1725. 10.1016\/S0891-5849(00)00229-X.","journal-title":"Free Radic Biol Med"},{"issue":"48","key":"248_CR19","doi-asserted-by":"publisher","first-page":"46116","DOI":"10.1074\/jbc.M209124200","volume":"277","author":"R Zhang","year":"2002","unstructured":"Zhang R, Brennan ML, Shen Z, MacPherson JC, Schmitt D, Molenda CE, Hazen SL: Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J Biol Chem. 2002, 277 (48): 46116-46122. 10.1074\/jbc.M209124200.","journal-title":"J Biol Chem"},{"issue":"1","key":"248_CR20","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1590\/S0066-782X2008001300015","volume":"91","author":"RM Roman","year":"2008","unstructured":"Roman RM, Wendland AE, Polanczyk CA: Myeloperoxidase and coronary arterial disease: from research to clinical practice. Arq Bras Cardiol. 2008, 91 (1): e11-19. 10.1590\/S0066-782X2008001300015.","journal-title":"Arq Bras Cardiol"},{"issue":"1","key":"248_CR21","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1172\/JCI117342","volume":"94","author":"A Daugherty","year":"1994","unstructured":"Daugherty A, Dunn JL, Rateri DL, Heinecke JW: Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest. 1994, 94 (1): 437-444. 10.1172\/JCI117342.","journal-title":"J Clin Invest"},{"issue":"17","key":"248_CR22","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1001\/jama.286.17.2136","volume":"286","author":"R Zhang","year":"2001","unstructured":"Zhang R, Brennan ML, Fu X, Aviles RJ, Pearce GL, Penn MS, Topol EJ, Sprecher DL, Hazen SL: Association between myeloperoxidase levels and risk of coronary artery disease. Jama. 2001, 286 (17): 2136-2142. 10.1001\/jama.286.17.2136.","journal-title":"Jama"},{"issue":"6","key":"248_CR23","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.amjmed.2003.10.025","volume":"116","author":"FW Asselbergs","year":"2004","unstructured":"Asselbergs FW, Reynolds WF, Cohen-Tervaert JW, Jessurun GA, Tio RA: Myeloperoxidase polymorphism related to cardiovascular events in coronary artery disease. Am J Med. 2004, 116 (6): 429-430. 10.1016\/j.amjmed.2003.10.025.","journal-title":"Am J Med"},{"issue":"1","key":"248_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000041062","volume":"104","author":"D Kutter","year":"2000","unstructured":"Kutter D, Devaquet P, Vanderstocken G, Paulus JM, Marchal V, Gothot A: Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit?. Acta Haematol. 2000, 104 (1): 10-15. 10.1159\/000041062.","journal-title":"Acta Haematol"},{"issue":"2","key":"248_CR25","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1067\/mhj.2001.116769","volume":"142","author":"B Nikpoor","year":"2001","unstructured":"Nikpoor B, Turecki G, Fournier C, Theroux P, Rouleau GA: A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians. Am Heart J. 2001, 142 (2): 336-339. 10.1067\/mhj.2001.116769.","journal-title":"Am Heart J"},{"key":"248_CR26","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1196\/annals.1372.022","volume":"1084","author":"FN Ahmed","year":"2006","unstructured":"Ahmed FN, Naqvi FN, Shafiq F: Lipid peroxidation and serum antioxidant enzymes in patients with type 2 diabetes mellitus. Ann N Y Acad Sci. 2006, 1084: 481-489. 10.1196\/annals.1372.022.","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"248_CR27","first-page":"CR406","volume":"14","author":"JJ Wiersma","year":"2008","unstructured":"Wiersma JJ, Meuwese MC, van Miert JN, Kastelein A, Tijssen JG, Piek JJ, Trip MD: Diabetes mellitus type 2 is associated with higher levels of myeloperoxidase. Med Sci Monit. 2008, 14 (8): CR406-410.","journal-title":"Med Sci Monit"},{"issue":"2","key":"248_CR28","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1042\/bj2640447","volume":"264","author":"BE Britigan","year":"1989","unstructured":"Britigan BE, Hassett DJ, Rosen GM, Hamill DR, Cohen MS: Neutrophil degranulation inhibits potential hydroxyl-radical formation. Relative impact of myeloperoxidase and lactoferrin release on hydroxyl-radical production by iron-supplemented neutrophils assessed by spin-trapping techniques. Biochem J. 1989, 264 (2): 447-455.","journal-title":"Biochem J"},{"issue":"4","key":"248_CR29","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1023\/B:BIRY.0000026205.89894.25","volume":"69","author":"OB Ekmekci","year":"2004","unstructured":"Ekmekci OB, Donma O, Sardogan E, Yildirim N, Uysal O, Demirel H, Demir T: Iron, nitric oxide, and myeloperoxidase in asthmatic patients. Biochemistry (Mosc). 2004, 69 (4): 462-467. 10.1023\/B:BIRY.0000026205.89894.25.","journal-title":"Biochemistry (Mosc)"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-9-27.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2261-9-27\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-9-27","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-9-27.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T21:44:49Z","timestamp":1630446289000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/1471-2261-9-27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,23]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["248"],"URL":"https:\/\/doi.org\/10.1186\/1471-2261-9-27","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,23]]},"assertion":[{"value":"12 January 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"27"}}